Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019

Lack of age-appropriate commercially drug products availability is a common problem in pediatric therapeutics; this population needs improved and safer drug delivery. In addition, biopharmaceutic aspects, dosage requirements, and swallowing abilities demand pediatric forms different to adult formula...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pharmaceutics
Autores principales: delMoral-Sanchez, Jose-Manuel, Gonzalez-Alvarez, Isabel, Gonzalez-Alvarez, Marta, Navarro-Ruiz, Andres, Bermejo, Marival
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7238124/
https://ncbi.nlm.nih.gov/pubmed/32244848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12040316
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares